# OneBlood, Inc. – FDA Inspection, Feb 9, 2022

Source: https://www.keypedia.com/records/fda_inspections/oneblood-inc/7257e527-59f0-46f9-943f-0866b45088a4
Source feed: FDA_Inspections

> FDA inspection 1162423 of OneBlood, Inc., February 09, 2022. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1162423
- Company Name: OneBlood, Inc.
- Inspection Date: 2022-02-09
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1250131 - 2024-09-24
- [FDA Inspection 1081205 - 2019-02-26](https://www.keypedia.com/records/fda_inspections/oneblood-inc/d4274806-8b3e-49c5-b97b-36dcc2829714)
- FDA Inspection 997062 - 2016-12-14
- FDA Inspection 913508 - 2015-02-11
- FDA Inspection 827219 - 2013-04-09

Company: https://www.keypedia.com/companies/oneblood-inc/65af44b6-efd2-452e-bc8f-36508a8f1510

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d